The following discussion should be read in conjunction with our financial statements, including the notes thereto, appearing elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward looking statements. Our financial statements are stated in United States Dollars and are prepared in accordance with the United States Generally Accepted Accounting Principles.





Results of Operations

The Company has incurred losses since inception resulting in an accumulated deficit of $2,127,583 as of June 30, 2022. Our financial statements have been prepared assuming that we will continue as a going concern and, accordingly, do not include adjustments relating to the recoverability and realization of assets and classification of liabilities that might be necessary should we be unable to continue in operation.

We will require additional capital to meet our short- and long-term operating requirements. We expect to raise additional capital through, among other things, the sale of equity securities.

Three and six months ended June 30, 2022 ("2022 second quarter") compared to the three and six months ended June 30, 2021 ("2021 second quarter")





Revenues

Revenues decreased by $154 and $435, or 78.86% and 89.88%, in the three and six months ended June 30, 2022, respectively, compared to the three and six months ended June 30, 2021. The decline for the three and six months period was across all product lines. COVID-19 has impacted our overall business due to change of interest in small cap market investments particularly. This has limited our ability to raise capital for advertising and marketing, thus reducing revenues in the first period. The decrease in sales for subscriptions and supplements was directly associated to a reduction in advertising spend for the quarter. The reduced advertising spending also impacted the number of new customers we acquired for the period, this included subscriptions and supplement product lines.





Costs and Expenses

Total costs and operating expenses decreased $12,303 and $6,443, or 18.27% and 4.59%, in the three and six months ended June 30, 2022, respectively, compared to the three and six months ended June 30, 2021. The decrease in operating costs and expenses was due to savings initiatives to offset the decline in revenue.





   ·  Cost of revenue decreased $1,833 and $2,924, or 23.06% and 17.87%, in the
      three and six months ended June 30, 2022, respectively, compared to the
      three and six months ended June 30, 2021. Our cost of revenue includes the
      cost of the supplements we sell as well as shipping and handling costs for
      shipments to customers. The increase in cost of revenues as a percent of
      revenues is due to the decline in revenue across all product lines.

   ·  Selling, general and administrative expenses decreased $10,470 and $3,519
      or 17.63% and 2.83%, in the three and six months ended June 30, 2022,
      respectively, compared to the three and six months ended June 30, 2021. The
      decrease in SG&A is principally attributable to decreases in consulting and
      accounting expenses, legal expenses, office expenses and general expenses.




Net Loss

Our net loss for the six months ended June 30, 2022 was $140,305 compared to $145,762 for the six months ended June 30, 2021. Our net loss for the three months ended June 30, 2022 was $58,118 compared to $70,304 for the three months ended June 30, 2021. Decrease in net loss are attributable to the decrease in revenues which was offset by the decrease in costs and expenses.







18

Liquidity and capital resources





Liquidity is the ability of a company to generate sufficient cash to satisfy its
needs for cash. The following table summarizes our total current assets, total
current liabilities and working capital deficit at June 30, 2022 as compared to
December 31, 2021.



                              June 30,         December 31,
                                2022               2021
                             (unaudited)

Total current assets        $      36,802     $       25,390
Total current liabilities   $     603,973     $      517,256
Working capital deficit     $    (567,171 )   $     (491,866 )

The increase in total current assets between the periods primarily reflects an increase in cash and prepaid expenses. The increase in total current liabilities reflects an increase in notes payable. We do not have any capital commitments and do not have any external sources of working capital available.

Going concern and management's liquidity plans

The COVID-19 pandemic has materially and adversely impacted the U.S. economy and financial markets, with legislative and regulatory responses including unprecedented monetary and fiscal policy actions across all sectors, and there is significant uncertainty as to timing of stabilization and recovery. The extent of the COVID-19 impacts will depend on future actions and outcomes, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the outbreak, the short-term and long-term economic impact of the outbreak (including the effect on advertising activity, consumer discretionary spending and our employees), and the actions taken to mitigate the impact of the virus, and the pace of economic and financial market recovery when the COVID-19 pandemic subsides, among others.

The full impact of the COVID-19 outbreak continues to evolve as of the date of this report. Given the daily evolution of the COVID-19 outbreak and the global responses to curb its spread, the Company is not able to estimate adverse effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022.

We have experienced recurring operating losses and negative operating cash flows and have financed our recent working capital requirements primarily through the issuance of equity securities. During the six months ended June 30, 2022 and 2021, we have reported net losses of $140,305 and $145,762, respectively. As of June 30, 2022, we had a working capital deficit of $567,171, our accumulated deficit was $2,127,583. These factors, among others, raise substantial doubt about our ability to continue as a going concern. Our unaudited Condensed Financial Statements do not include any adjustments that might result from the outcome of this uncertainty. The accompanying Condensed Financial Statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. There are no assurances we will be successful in our efforts to report profitable operations or to continue as a going concern, in which event investors would lose their entire investment in our company.

Our ability to continue to grow our business is dependent upon our ability to raise additional sufficient capital to fund our operating expenses, including advertising, until such time, if ever, that we are able to report profitable operations, as well as for our short-term and long-term growth plans. We do not generate operating income and we are presently are relying on cash we receive from the holdback receivable to pay our operating expenses. Our management estimates that we require approximately $5,500,000 in additional working capital during the next 12 months in order to meet our current business objectives, including the development of new indicators for our Lifestyle Blueprint platform, the addition of print versions of our DWD Protocol, expanding our supplement product line and additional subscription content offerings for our customers. This additional working capital is also necessary to fund increases in our advertising and marketing costs, costs associated with the development of additional infrastructure to support our expected growth, as well as funds to pay our operating expenses and general working capital. While we were successful in raising funds privately during late 2017 and into the first quarter of 2018, and will seek to do so in future periods, we do not have any firm commitments to provide any additional capital to us. There are no assurances we will be successful in securing the additional capital necessary to grow our company and pay our operating expenses. Any delay in raising sufficient funds could adversely impact our ability to continue to increase our revenues in future periods. In addition, if we are unable to raise the necessary additional working capital, we may be forced to reduce certain operating expenses in an effort to conserve our working capital which will adversely impact our revenues and results of operations in future periods and there are no assurances we could continue as a going concern.





19









Summary of cash flows



                                              June 30,          June 30,
                                                2022              2021
                                             (unaudited)       (unaudited)

Net cash used in operating activities $ (69,059 ) $ (62,889 ) Net cash provided by investing activities $

           -     $           -

Net cash provided by financing activities $ 80,000 $ 55,662

The increase in cash used in our operating activities in the six months ended June 30, 2022 as compared to the six months ended June 30, 2022 is due to the increase in net loss offset by increase in prepaid expenses and increase in accounts payable and accrued expenses.

There was no net cash provided by or used in investing activities during the six months ended June 30, 2022 and 2021 second quarters.

Net cash provided by financing activities during the six months ended June 30, 2022 reflects proceeds from notes payable.





Commitments and Contingencies

Information regarding our Commitments and Contingencies is contained in Note 6 to the unaudited Condensed Financial Statements.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.





Emerging Growth Company

We are an "emerging growth company," as defined in the Jumpstart Our Business Startups Act of 2012, or the "JOBS Act", and we are permitted to take advantage of certain exemptions from various public company reporting requirements, including not being required to have our internal controls over financial reporting audited by our independent registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or the "Sarbanes-Oxley Act", reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments. We may take advantage of these exemptions until we are no longer an "emerging growth company." In addition, the JOBS Act provides that an "emerging growth company" can delay adopting new or revised accounting standards until such time as

those standards apply to private companies.

We have elected to use the extended transition period for complying with new or revised accounting standards under the JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.

We could remain an emerging growth company for up to five years, or until the earliest of:





   ·  the last day of the first fiscal year in which our annual gross revenues
      exceed $1.07 billion;

   ·  the date that we become a "large accelerated filer" as defined in Rule
      12b-2 under the Securities Exchange Act of 1934, as amended, or the
      "Exchange Act", which would occur if the market value of our common stock
      that is held by non-affiliates exceeds $700 million as of the last business
      day of our most recently completed second fiscal quarter; or

   ·  the date we have issued more than $1 billion in non-convertible debt during
      the preceding three-year period.

At this time, we expect to remain an emerging growth company until possibly as late as 2023. References herein to "emerging growth company" have the meaning associated with that term in the JOBS Act.

© Edgar Online, source Glimpses